VU0359595

VU0359595
Item number Size Datasheet Manual SDS Delivery time Quantity Price
Cay10955-1 1 mg -

6 - 10 business days*

55.00€
Cay10955-5 5 mg -

6 - 10 business days*

191.00€
Cay10955-10 10 mg -

6 - 10 business days*

323.00€
Cay10955-25 25 mg -

6 - 10 business days*

741.00€
 
Phospholipase D (PLD) is an enzyme that cleaves the head group from phospholipids, producing the... more
Product information "VU0359595"
Phospholipase D (PLD) is an enzyme that cleaves the head group from phospholipids, producing the second messenger phosphatidic acid. Two mammalian isoforms of PLD, PLD1, and PLD2, have been identified, with multiple splice variants of each. Although the two isoforms share structural and functional features, they are regulated differently and apparently subserve distinct roles. VU0359595 is an inhibitor of PLD1 (IC50 = 3.7 nM) that is >1,700-fold selective over PLD2 (IC50 = 6.4 µM). Preliminary evidence suggests that VU0359595 does not interact with the catalytic site of PLD, but instead may bind and inhibit PLD through an allosteric site.Formal Name: (1R,2R)-N-[(1S)-2-[4-(5-bromo-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-phenyl-cyclopropanecarboxamide, (1S,2S)-N-[(1S)-2-[4-(5-bromo-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-phenyl-cyclopropanecarboxamide. Synonyms: CID-53361951, ML-270. Molecular Formula: C25H29BrN4O2. Formula Weight: 497.4. Purity: >95% (mixture of diastereomers). Formulation: (Request formulation change), A crystalline solid. Solubility: DMSO: 5 mg/ml. lambdamax: 293 nm. SMILES: C[C@@H](CN1CCC(CC1)N2C(NC3=C2C=CC(Br)=C3)=O)NC([C@@H]4C[C@H]4C5=CC=CC=C5)=O.C[C@@H](CN6CCC(CC6)N7C(NC8=C7C=CC(Br)=C8)=O)NC([C@H]9C[C@@H]9C%10=CC=CC=C%10)=O. InChi Code: InChI=1S/2C25H29BrN4O2/c2*1-16(27-24(31)21-14-20(21)17-5-3-2-4-6-17)15-29-11-9-19(10-12-29)30-23-8-7-18(26)13-22(23)28-25(30)32/h2*2-8,13,16,19-21H,9-12,14-15H2,1H3,(H,27,31)(H,28,32)/t16-,20+,21-,16-,20-,21+/m00/s1. InChi Key: ZJJZIOCVJFWBFM-QDZXWRQZSA-N.
Keywords: CID-53361951, ML-270, (1R,2R)-N-[(1S)-2-[4-(5-bromo-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-phenyl-cyclopropanecarboxamide, (1S,2S)-N-[(1S)-2-[4-(5-bromo-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]
Supplier: Cayman Chemical
Supplier-Nr: 10955

Properties

Application: PLD1 inhibitor
MW: 497.4 D
Formula: C25H29BrN4O2
Purity: >95% (mixture of diastereomers)
Format: Crystalline Solid

Database Information

KEGG ID : K01115 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "VU0359595"
Write a review
or to review a product.
Viewed